MSK
Search
- Page Path
- HOME > Search
Journal Article
- Epidemiological Features and Resistance Pattern in Uropathogens Isolated from Chronic Bacterial Prostatitis
- Tommaso Cai , Sandra Mazzoli , Francesca Meacci , Vieri Boddi , Nicola Mondaini , Gianni Malossini , Riccardo Bartoletti
- J. Microbiol. 2011;49(3):448-454. Published online June 30, 2011
- DOI: https://doi.org/10.1007/s12275-011-0391-z
- 44 View
- 0 Download
- 32 Crossref
-
Abstract
- Chronic bacterial prostatitis (CBP) is, usually, caused by uropathogens, especially gram-negative bacilli, although infection is sometimes due to Gram-positive and atypical microorganisms. A recent increasing in prevalence of Gram-positive strains has been reported. The aim of this study was to explore the epidemiological features and resistance rates in uropathogens isolated from CBP outpatients in last 10 years. All consecutive outpatients with demonstrated CBP attending a single Sexually Transmitted Disease centre from January 1997 and December 2008, were enrolled and underwent microbiological cultures in first void early morning urine, midstream urine, expressed prostatic secretion, and post prostate massage urine. Prevalence of different bacterial strains was stratified in four different periods: 1997-1999, 2000-2002, 2003-2005, 2006-2008. Any changes observed in epidemiological features and resistance rates in uropathogens over the whole study period have been analyzed. The present study has been planned, thus, as in vitro study. From 6,221 patients, 4,601 Gram-positive and 1,620 Gram-negative bacterial strains have been isolated. Enterococcus faecalis and Escherichia coli strains are the first and second frequent pathogens found, respectively. Significant differences between E. faecalis prevalence in the 1997-1999 and 2006-2008 periods were found. E. coli showed a significant difference between prevalence in 1997-1999 and 2006-2008 periods. Gram-positive organisms showed a decreasing of susceptibility to ciprofloxacin as well as Gram-negative strains, while a good susceptibility to the levofloxacin was evidenced. E. faecalis prevalence seemed to be raised in 2006-2008 periods. Moreover, a decreasing of activity of ciprofloxacin and a good activity profile of levofloxacin have been reported.
-
Citations
Citations to this article as recorded by
- Could Urology’s Antimicrobial Stewardship Be Enhanced by the Routine Use of the Meares and Stamey Test?
Simone Botti, Tommaso Ceccato, Michele Rizzo, Giovanni Liguori, Alessandro Zucchi, Alessandro Palmieri, Truls E. Bjerklund Johansen, Tommaso Cai
Diagnostics.2025; 15(8): 1002. CrossRef - Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary Disorders
Sara Palumbo, Giuseppe Lucarelli, Francesco Lasorsa, Rocco Damiano, Riccardo Autorino, Achille Aveta, Gianluca Spena, Sisto Perdonà, Pierluigi Russo, Carlo Giulioni, Angelo Cafarelli, Marco Finati, Salvatore Siracusano, Savio Domenico Pandolfo
Urology.2025;[Epub] CrossRef - Pathogen Detection and Diagnostic Scenarios in Chronic Prostatitis
Vittorio Magri, Gianpaolo Perletti, Konstantinos Stamatiou
Diagnostics.2025; 15(6): 762. CrossRef - Microbiota of prostate secretion in patients with chronic abacterial prostatitis
Z. A. Kadyrov, M. V. Faniev, Sh. V. Ramishvili, V. S. Stepanov, A. V. Ignatev, Sh. G. Mashaneishvili
Andrology and Genital Surgery.2024; 25(1): 73. CrossRef - Molecular detection of urinary microbiome in prostate cancer patients
Shadab Mestri, Satisha Hegde, Makhadumsab Toragall, Sridevi I. Puranik, M. A. Mujeeb, Shridhar C. Ghagane
Journal of The Academy of Clinical Microbiologists.2024; 25(2): 44. CrossRef - Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria
Sharon O. Akinpelu, Grace I. Olasehinde, Stephen O. Ikuerowo, Olayemi O. Akinnola
BMC Microbiology.2024;[Epub] CrossRef - Comparative analysis of the microbiota of prostate secretion in patients with chronic abacterial prostatitis of categories IIIa and IIIb
Z. A. Kadyrov, M. V. Faniev, Sh. V. Ramishvili, V. S. Stepanov, A. V. Ignatev, Sh. G. Mashaneishvili
Andrology and Genital Surgery.2024; 25(2): 93. CrossRef - Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis
Roy H. Stevens, Hongming Zhang, Michal Kajsik, Rafał Płoski, Malgorzata Rydzanicz, Peter Sabaka, Stanislav Šutovský
Frontiers in Medicine.2023;[Epub] CrossRef - Pharmacotherapeutic interventions for the treatment of bacterial prostatitis
Ester Marquez-Algaba, Joaquin Burgos, Benito Almirante
Expert Opinion on Pharmacotherapy.2022; 23(9): 1091. CrossRef - Safety considerations with new antibacterial approaches for chronic bacterial prostatitis
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou, Vittorio Magri
Expert Opinion on Drug Safety.2022; 21(2): 171. CrossRef - Reflux-related Complications in Patients with Chronic Calculous Prostatitis and Benign Prostate Hyperplasia After Surgical Removal of Prostatic Hyperplasia and Stones
Mykhailo Ukhal, Oleh Semaniv, Ivan Pustovoit, Heorhii Samunzhi
Health of Man.2022; (4): 42. CrossRef - One, No One and One Hundred Thousand: Patterns of chronic prostatic inflammation and infection
Konstantinos Stamatiou, Evangelia Samara, Richard Lacroix, Hippocrates Moschouris, Gianpaolo Perletti, Vittorio Magri
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef - Does the microbiota spectrum of prostate secretion affect the clinical status of patients with chronic bacterial prostatitis?
Mikhail Kogan, Yulia Naboka, Akhmed Ferzauli, Khalid Ibishev, Irina Gudima, Ruslan Ismailov
International Journal of Urology.2021; 28(12): 1254. CrossRef - Pharmacological Interventions for Bacterial Prostatitis
Situ Xiong, Xiaoqiang Liu, Wen Deng, Zhengtao Zhou, Yulei Li, Yechao Tu, Luyao Chen, Gongxian Wang, Bin Fu
Frontiers in Pharmacology.2020;[Epub] CrossRef - Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
Tommaso Cai, Raffaella Santi, Irene Tamanini, Ilaria Camilla Galli, Gianpaolo Perletti, Truls E. Bjerklund Johansen, Gabriella Nesi
International Journal of Molecular Sciences.2019; 20(15): 3833. CrossRef - Actividad y concentraciones de antibióticos en muestras clínicas de pacientes con prostatitis crónica bacteriana
V. Heras-Cañas, B. Gutiérrez-Soto, H. Almonte-Fernández, A. Lara-Oya, J.M. Navarro-Marí, A. Garrido-Frenich, F. Vázquez-Alonso, J. Gutiérrez-Fernández
Actas Urológicas Españolas.2017; 41(10): 631. CrossRef - Antibiotic activity and concentrations in clinical samples from patients with chronic bacterial prostatitis
V. Heras-Cañas, B. Gutiérrez-Soto, H. Almonte-Fernández, A. Lara-Oya, J.M. Navarro-Marí, A. Garrido-Frenich, F. Vázquez-Alonso, J. Gutiérrez-Fernández
Actas Urológicas Españolas (English Edition).2017; 41(10): 631. CrossRef - Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse
Konstantinos Stamatiou, Nikolaos Pierris
Investigative and Clinical Urology.2017; 58(4): 271. CrossRef - Prostatitis crónica bacteriana. Estudio clínico y microbiológico de 332 casos
Víctor Heras-Cañas, Blanca Gutiérrez-Soto, María Luisa Serrano-García, Fernando Vázquez-Alonso, José María Navarro-Marí, José Gutiérrez-Fernández
Medicina Clínica.2016; 147(4): 144. CrossRef - Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
Ibai Los-Arcos, Carles Pigrau, Dolors Rodríguez-Pardo, Nuria Fernández-Hidalgo, Antonia Andreu, Nieves Larrosa, Benito Almirante
Antimicrobial Agents and Chemotherapy.2016; 60(3): 1854. CrossRef - Chronic bacterial prostatitis. Clinical and microbiological study of 332 cases
Víctor Heras-Cañas, Blanca Gutiérrez-Soto, María Luisa Serrano-García, Fernando Vázquez-Alonso, José María Navarro-Marí, José Gutiérrez-Fernández
Medicina Clínica (English Edition).2016; 147(4): 144. CrossRef - Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice
Ju-Hee Han, Jong-Hwan Park, Bo-Yeon Kim, Seo-Na Chang, Tae-Hyoun Kim, Jae-Hak Park, Dong-Jae Kim
Journal of Veterinary Science.2015; 16(3): 281. CrossRef - A comparison of monomicrobial versus polymicrobial Enterococcus faecalis bacteriuria in a French University Hospital
C. Fourcade, L. Canini, J.-P. Lavigne, A. Sotto
European Journal of Clinical Microbiology & Infectious Diseases.2015; 34(8): 1667. CrossRef - Chronic bacterial prostatitis in men with spinal cord injury
Jörg Krebs, Peter Bartel, Jürgen Pannek
World Journal of Urology.2014; 32(6): 1579. CrossRef - Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
Hitoshi Ishiguro, Takashi Kawahara
BioMed Research International.2014; 2014: 1. CrossRef - Salmonella prostatitis in a man with spinal cord injury
Jörg Krebs, Konrad Göcking, Jürgen Pannek
The Journal of Spinal Cord Medicine.2014; 37(1): 114. CrossRef - The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study
Riccardo Bartoletti, Tommaso Cai, Gabriella Nesi, Sara Albanese, Francesca Meacci, Sandra Mazzoli, Kurt Naber
World Journal of Urology.2014; 32(3): 737. CrossRef - Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study
Jiaquan Xiao, Ligang Ren, Huoxiang Lv, Qing Ding, Shuixin Lou, Wei Zhang, Zhichao Dong
Urologia Internationalis.2013; 91(4): 410. CrossRef - Antimicrobial Resistance Pattern inEnterococcus faecalisStrains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis
Yumi Seo, Gilho Lee
Korean Journal of Urology.2013; 54(7): 477. CrossRef - The Role of Asymptomatic Bacteriuria in Young Women With Recurrent Urinary Tract Infections: To Treat or Not to Treat?
T. Cai, S. Mazzoli, N. Mondaini, F. Meacci, G. Nesi, C. D'Elia, G. Malossini, V. Boddi, R. Bartoletti
Clinical Infectious Diseases.2012; 55(6): 771. CrossRef - Prostate cancer and inflammation: the evidence
Karen S Sfanos, Angelo M De Marzo
Histopathology.2012; 60(1): 199. CrossRef - Chronic Bacterial Prostatitis: Enterococcal Disease?
V. Magri, E. Marras, G. Perletti
Clinical Infectious Diseases.2011; 53(12): 1306. CrossRef
- Could Urology’s Antimicrobial Stewardship Be Enhanced by the Routine Use of the Meares and Stamey Test?
Research Support, Non-U.S. Gov't
- Rapid One Step Detection of Pathogenic Bacteria in Urine with Sexually Transmitted Disease (STD) and Prostatitis Patient by Multiplex PCR Assay (mPCR)
- Sang Rok Lee , Ji Min Chung , Young Gon Kim
- J. Microbiol. 2007;45(5):453-459.
- DOI: https://doi.org/2590 [pii]
- 52 View
- 0 Download
-
Abstract
- We developed a multiplex PCR (mPCR) assay to simultaneously detect Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma urealyticum, Corynebacterium spp. and seudomona aeruginosa. This method employs a single tube and multiple specific primers which yield 200, 281, 346, 423, 542, and 1,427 bp PCR products, respectively. All the PCR products were easily detected by agarose gel electrophoresis and were sequenced to confirm the specificity of the reactions. To test this method, DNA extracted from urine samples was collected from 96 sexually transmitted disease or prostatitis patients at a local hospital clinical center, and were subjected to the mPCR assay. The resulting amplicons were cloned and sequenced to exactly match the sequences of known pathogenic isolates. N. gonorrhoeae and Corynebacterium spp. were the most frequently observed pathogens found in the STDs and prostatitis patients, respectively. Unexpectedly, P. aeruginosa was also detected in some of the STD and prostatitis samples. More than one pathogen species was found in 10% and 80.7% of STD and prostatitis samples, respectively, indicating that STD and prostatitis patients may have other undiagnosed and associates. The sensitivity of the assay was determined by sing purified DNA from six pathogenic laboratory strains and revealed that this technique could detect pathogenic DNA at concentrations ranging from 0.018 to 1.899 pg/μl. Moreover, the specificities of this assay were found to be highly efficient. Thus, this mPCR assay may be useful for the rapid diagnosis of causative infectious STDs and prostatitis. useful for the infectious STDs and prostatitis.
First
Prev
TOP
